Carolina Clinical Research specializes in conducting clinical trials for infectious diseases. We have the facilities and expertise necessary to conduct clinical trials safely and effectively.
We currently are conducting two infectious disease trials: ACTIV-2: A Study for Outpaitents with COVID-19 and EFC16720: Dupliumab for the Treatment of Chronic Inducible Cold Urticaria
Eligible study participants can recieve study treatment and medications at no cost, and may be eligible for additional compensation, including study stipends, expense reimbursements, and free transportation.
Click Here for EFC16720 trial information